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Background: Central pain syndrome is characterized by a combination of abnormal pain sensations, and pain
medications often provide little or no relief. Accumulating animal and clinical studies have shown that impairments of
the spinothalamic tract (STT) and thalamocingulate pathway causes somatosensory dysfunction in central post-stroke
pain (CPSP), but the involvement of other neuronal circuitries in CPSP has not yet been systematically examined. The
aim of the present study was to evaluate changes in brain activity and neuronal circuitry using [14C]iodoantipyrine (IAP)
in an animal model of CPSP.
Results: Rats were subjected to lateral thalamic hemorrhage to investigate the characteristics of CPSP. Thermal and
mechanical hyperalgesia developed in rats that were subjected to thalamic hemorrhagic lesion. The medial prefrontal
cortex (mPFC), anterior cingulate cortex (ACC), striatum, thalamus, hypothalamus, and amygdala were more active in
the CPSP group compared with rats that were not subjected to lateral thalamic hemorrhage. The inter-regional
correlation analysis showed that regional cerebral blood flow in the mPFC was highly correlated with the amygdala in
the right brain, and the right brain showed complex connections among subregions of the ACC. Rats with CPSP
exhibited strong activation of the thalamocingulate and mPFC-amygdala pathways.
Conclusions: These results corroborate previous findings that the STT and thalamocingulate pathway are involved in
the pathophysiological mechanisms of CPSP symptoms. The mPFC, amygdala, and periaqueductal gray emerged as
having important correlations in pain processing in CPSP. The present data provide a basis for a neural correlation
hypothesis of CPSP, with implications for CPSP treatment.
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Many clinical symptoms are manifested after stroke, includ-
ing motor deficits, cognitive dysfunction, language problems,
emotional disturbances, social maladjustment, somatosen-
sory dysfunction, and central pain [1,2]. More than 8% of
stroke patients have neuropathic pain, termed central post-
stroke pain (CPSP) [3]. CPSP might result from many
somatosensory dysfunctions, including hypersensitivity and
allodynia. Some hypotheses of the pathophysiological mech-
anisms of somatosensory dysfunction have been proposed
to explain CPSP symptoms, such as the loss of somatic* Correspondence: bmbai@gate.sinica.edu.tw
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unless otherwise stated.sensations caused by the deafferentation of neurons in the
hemorrhagic area, hyperalgesia that results from the hyper-
excitability of central nociceptive neurons, and central disin-
hibition [4,5]. These pathophysiological mechanisms of
CPSP provide some insights for determining the possible
neural substrates of CPSP.
Several neural substrates, including cerebral activity, might
be involved in the pathophysiology of CPSP [6-8]. For
example, a recent study showed that the expression of
interleukin-1β in the hippocampus, prefrontal cortex, and
brainstem may be correlated with chronic neuropathic pain-
like behavior [9]. A review article reported that the descend-
ing pain modulation system, including the dorsolateral
prefrontal cortex, rostral anterior cingulate cortex (ACC),
amygdala, hippocampus, periaqueductal gray (PAG), andis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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regulates nociceptive processing [10]. The lateral and
medial pain pathways have been showed to govern the
homeostasis of nociception processing in coding the in-
tensity of pain [8,11-13]. Stroke patients with dysfunc-
tion in the lateral thalamus exhibited a disruption of
inhibition of signaling to the medial thalamus (MT),
resulting in mechanical allodynia and thermal hyper-
algesia [6,7]. CPSP of thalamic origin can be viewed as a
disinhibition disorder associated with thermoregulatory
integration. Additionally, the ventral posteromedial
thalamic nucleus (VPM)-dorsal posterior insular path-
way has been shown to inhibit pain processing in limbic
networks that consist of the MT, ACC, and PAG, sug-
gesting that CPSP may be attributable to the loss of the
aforementioned inhibition [14,15].
Human functional magnetic resonance imaging (fMRI)
studies have provided important evidence that the spi-
nothalamic tract (STT) and MT-ACC pathway might be
involved in CPSP [15-18]. For example, brain lesions of
the lateral and posterior thalamus and ventral nucleus-
pulvinar border zone have been shown to be associated
with a higher risk of developing CPSP after thalamic insult
[15]. A recent correlational study used clinical quantitative
sensory testing (QST), MRI, and single-photon emission
computed tomography (SPECT) and found that MRI and
SPECT images of thalamic and parietal cortex lesions
were correlated with CPSP-related allodynia symptoms in
QST tests [16]. A recent human fMRI study dissociated
differences in thalamic subregions (e.g., ventral posterolat-
eral [VPL] and posterior portion [VMpo] of the ventral
medial nucleus) in CPSP, indicating that the VPL but not
VMpo plays a crucial role in CPSP [17]. Furthermore, an-
other fMRI study indicated that the contralateral somato-
sensory cortex and bilateral mid/posterior insula, anterior
insula, and posterior cingulate were activated during ex-
posure to acute pain stimulation [18]. Therefore, the STT
and MT-ACC pathway may be critically involved in CPSP
symptoms.
A growing body of evidence indicates that the activa-
tion of medial prefrontal cortex (mPFC)-to-amygdala
circuitry is involved in pain-related emotion and gov-
erns nociception in rodents [19-23]. Therefore, the
present study evaluated whether the mPFC-amygdala
pathway, STT, MT-ACC pathway, and other neural sub-
strates are involved in CPSP.
Brain responses in CPSP patients have been investigated
using functional brain mapping [15,16,24]. Functional
magnetic resonance imaging measures global neuronal ac-
tivity in response to specific stimuli. Positron emission
tomography (PET) is another brain mapping approach
that determines active brain localization using a radio-
active substance. Functional magnetic resonance imaging
and PET are powerful tools with high spatial resolutionfor evaluating brain activity. Moreover, fMRI can provide
real-time brain mapping data. However, the costs for fMRI
and PET are high and/or require anesthesia. In contrast,
the [14C]iodoantipyrine (IAP) uptake method requires no
anesthesia and is less expensive. The [14C]IAP uptake
method also has some limitations. It involves the indirect
observation of regional cerebral blood flow (rCBF) by as-
suming a brain activity-cerebral blood flow relationship. The
most critical symptom associated with CPSP is the sensation
of constant burning (i.e., spontaneous pain) [25]. Thus, to
spontaneously measure the brain events that occur in a
pathological state, the [14C]IAP uptake method is suitable
for mapping brain activity during spontaneous pain.
In human studies, hypersensitivity and allodynia asso-
ciated with CPSP have been shown to be important
symptoms [1]. A novel animal model of CPSP has been
developed recently, suggesting that lesions of the ventral
basal nucleus (VB) of the thalamus can cause hypersen-
sitivity and allodynia in CPSP [26]. No animal studies
have systematically and comprehensively investigated
alterations in brain activity related to hypersensitivity
and allodynia in an animal model of CPSP. The aim of
the present study was to utilize [14C]IAP radioactivity to
evaluate brain activity and circuitry changes after lesions
of the VB in rats. Furthermore, some neural circuits,
including the STT and MT-ACC pathway, mPFC-
amygdala pathway, and other neural substrates, were
examined to investigate the neural circuitries that are
involved in brain activation associated with CPSP.Results
Correlations between [14C]IAP radioactivity and imaging
signals
Brain activity was correlated with [14C]IAP signal intensity
in brain images. The pixel intensity of brain images using
the [14C]IAP method can elucidate metabolism in the
brain and allow quantitative analyses. To quantify the
pixel intensity of images of different brain slices, image
normalization is very important. We first defined the
range of signal intensities to be included in the image ana-
lysis. The range of the environmental background signal
was 25.811-46.979 counts per minute (CPM), and the
signal of the [14C]IAP 0.001 μCi filter paper was 42 CPM.
Therefore, pixels with a signal intensity < 0.001 μCi were
considered background. Five dose ranges (0.001-10
μCi 14C) could be displayed as gray-scale pixels on the
images. The doses of [14C]IAP radioactivity were positively
correlated with the pixel intensity and radioactivity count
on a logarithmic scale. The pixel intensity was also shown
to be positively correlated with radioactivity count
(r = 0.94, p < 0.05), with a linear regression equation was
obtained between the pixel intensity and radioactivity
count, (Equation 1, Figure 1A).
Figure 1 Standard curves of autoradiography. A. Correlations between pixel intensity and pixel count. The pixel intensity was highly
correlated with pixel count. B. Pixel intensity increased with increasing exposure time. The optimal resolution appeared on day 4.
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The pixel intensity was positively correlated with ex-
posure time. The intensity increased from day 1 to day
5. However, the pixel intensity was not significantly dif-
ferent (p > 0.05) between day 4 and day 5. Thus, 4 days
was determined to be the optimal exposure time for
[14C]IAP to obtain maximal pixel intensity (Figure 1B).
Behavioral hyperalgesia occurred after thalamic lesion
The experimental timeline for the brain lesions, behavioral
measurements, and brain imaging is illustrated in Figure 2A.
A typical collagenase-induced lesion in the VPL and VPM
in frozen brain slices is shown in Figure 2B (white arrow).
The lesion sites from all of the histological samples are
encircled with red lines and overlap in the corresponding
brain atlas. The lesion sites were all confirmed and localized
in the VB area (Figure 2B).
To test the behavioral influence of thalamic lesions on
thermal nociception and mechanical pain threshold, sham
and CPSP rats were evaluated using the plantar test and
von Frey test. The plantar test was performed to determine
changes in thermal nociception. A 2 × 5 mixed two-way
analysis of variance (ANOVA) indicated that thermal pain
threshold in the CPSP group was significantly decreased
compared the sham group (F1,40 = 45.86, p < 0.05). The sig-
nificant difference between groups lasted from week 1 to
week 5 of the experiment (Tukey’s Honestly Significant Dif-
ference (HSD) post hoc test, all p < 0.05; Figure 2C). No sig-
nificant difference in pain threshold was found between the
different weeks after collagenase or saline treatment in each
group (F4,160 = 0.43, p > 0.05).
Changes in mechanical pain thresholds were assessed in
the von Frey test. Mechanical thresholds in the CPSP
group were significantly lower than in the sham group
(2 × 5 mixed two-way ANOVA; F1,40 = 15.55, p < 0.05). Asignificant group × lesion weeks interaction was observed
(F4,160 = 2.81, p < 0.05). CPSP rats exhibited significant
changes in mechanical hyperalgesia from week 1 to week
5 (Tukey’s HSD post hoc test, all p < 0.05; Figure 2D). No
significant difference in pain thresholds was found be-
tween the different weeks after collagenase or saline treat-
ment in each group (F4,160 = 2.67, p > 0.05).
Brain imaging of [14C]IAP
To examine the brain areas that are involved in CPSP
symptoms and their signal intensity, Statistical Paramet-
ric Mapping (SPM) was used. Whole-brain images were
composed of a sequence of images in a coronal section
that were normalized and analyzed by SPM. The differ-
ences between the sham and CPSP groups were indexed
by subtracting the sham group from the CPSP group.
Pixel counts were significantly different (p < 0.05) and
are presented in pseudo color in Figure 3. Compared
with the sham group, the CPSP group showed significant
alterations in the pixel count ratio, reflecting [14C]IAP
expression in some major brain regions, including the
cortex, striatum, thalamus, hypothalamus, and amygdala.
To quantitatively analyze the SPM results, a 2 × 31 × 2
three-way (group vs. brain area vs. hemisphere) ANOVA
was performed, indicating significant effects of group
(F1,744 = 2492.36, p < 0.05) and brain area (F30,744 =
173.66, p < 0.05) and a significant group × brain area
interaction (F30,744 = 98.34, p < 0.05). No significant effect
of hemisphere was found (F1,744 = 0.00, p > 0.05), with no
group × hemisphere interaction (F1,744 = 0.08, p > 0.05),
brain area × hemisphere interaction (F30,744 = 0.45, p >
0.05), or group × brain area × hemisphere interaction
(F30,744 = 0.42, p > 0.05). Furthermore, a 2 × 31 two-way
(group vs. brain area) ANOVA indicated significant ef-
fects of group (F1,806 = 2608.01, p < 0.05) and brain area
(F30,806 = 181.72, p < 0.05) and a significant group × brain
area interaction (F30,806 = 102.90, p < 0.05). The post hoc
Figure 2 Experimental timeline and example of mechanical and thermal hyperalgesia after lesion of the VPL and VPM. A. Experimental
timeline of [14C] experiment. B. Example of collagenase-induced lesion in the VPL and VPM 1 month after injection. C and D. Plantar test and von
Frey test on the left hindpaw in the sham and CPSP groups on day 35. p < 0.05 (two-way ANOVA followed by post hoc test). The results showed
that the CPSP group had lower pain thresholds than the sham group.
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eral brain regions were significantly different between
the CPSP and sham groups (all p < 0.05), such as the cin-
gulate cortex area 1 (Cg1), somatosensory cortex (S1),
granular insular cortex (GI), hippocampus (Hippo), thal-
amus (e.g., mediodorsal thalamic nucleus [MD], VB,
ventrolateral thalamic nucleus [VL], and ventromedial
thalamic nucleus [VM]), hypothalamus (e.g., lateral
hypothalamic area [LH] and ventromedial hypothalamic
nucleus [VMH]), amygdala, and PAG. Overall, [14C] IAP
was high uptake in the mPFC and ACC in the CPSP
group and showed the strongest [14C] signals in the
brain images. Significant differences in radioactivity in
many brain areas are listed in Table 1.
Region-of-interest analysis
To further evaluate changes in brain areas associated
with CPSP symptoms, a region-of-interest (ROI) analysis
was conducted. Different brain areas related to CPSP
were distinguished and quantitatively analyzed. The ROIanalysis was conducted based on the results of the func-
tional brain images of [14C]-IAP uptake shown in
Figure 3. The assignment of the ROIs for specific brain
areas is shown in Figure 4A. A 2 × 31 × 2 three-way
(group vs. brain area vs. hemisphere) ANOVA was used
for the analysis, which revealed significant main effects
of group (F1,744 = 29.55, p < 0.05), brain area (F30,744 =
119.12, p < 0.05), and hemisphere (F1,744 = 18.05, p <
0.05), a group × brain area interaction (F30,744 = 17.44,
p < 0.05), a brain area × hemisphere interaction
(F30,744 = 4.94, p < 0.05), and a group × brain area × hemi-
sphere interaction (F30,744 = 1.88, p < 0.05). No group ×
hemisphere interaction was found (F1,744 = 0.30, p > 0.05).
A 2 × 31 two-way ANOVA (group vs. brain area) was
performed to analyze ROI scores, which revealed signifi-
cant main effects of group (F1,806 = 24.64, p < 0.05) and
brain area (F30,806 = 99.31, p < 0.05) and a group × brain
area interaction (F30,806 = 14.54, p < 0.05). The specific
ROIs in the sham control and CPSP groups in the left
and right hemispheres were measured and analyzed
Figure 3 Key brain regions that showed significant differences in pixel counts between the CPSP and sham groups. The results were obtained by
differential subtraction between the CPSP and sham groups. The signals in the cortex, thalamus, hypothalamus, and amygdala in the CPSP group were
significantly higher than in the sham group, and the signal in the ventral basal nucleus in the CPSP group was significantly lower than in the sham group.
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nificant differences were found in the infralimbic cortex (IL),
Cg1, M2, dorsal agranular insular cortex (AID), ventral agra-
nular insular cortex (AIV), Hippo-3, and PAG between the
sham and CPSP groups (all p < 0.05; Figure 4B). In contrast,
the right hemisphere showed significant differences in the
IL, prelimbic cortex (PrL), Cg1-1, VB, and amygdala-2 (all
p < 0.05; Figure 4C). Major differences in [14C]-IAP signals
were found between the CPSP and sham groups in the cor-
tex, thalamus, hypothalamus, amygdala, and PAG. These re-
sults suggest that the cortex on both sides of the brain
might be involved in CPSP, and the hippocampus and PAG
in the left hemisphere were activated solely in the CPSP
group. The VB of the right thalamus exhibited a reduction,
and this reduction appeared to result from the hemorrhagic
lesion. The significant differences in the ROI analysis are
presented in Table 1.
ROI vs. behavior correlation analysis
To evaluate whether these brain regions showed significant
differences that were linked with nociceptive behavioral re-
sponses after the thalamic hemorrhagic lesion, Pearsoncorrelations were conducted for pain-related behavioral re-
sponses and selected brain mapping ROIs that exhibited sig-
nificant differences with the SPM and ROI scores in the
ANOVA. The sham group did not exhibit correlations be-
tween the ROIs and plantar test results (r= 0.01, p > 0.05) or
von Frey test results (r= 0.01, p > 0.05). In contrast, in the
CPSP group, significant negative correlations were observed
between the ROIs and plantar test results (r=−0.13, p <
0.05), with no correlation between the ROIs and von Frey
test results (r= 0.09, p > 0.05; Table 2). The results of these
two behavioral tests showed significant positive correlations
in the sham group (r= 0.50, p < 0.05) and significant nega-
tive correlations in the CPSP group (r=−0.26, p < 0.05), in-
dicating that these two behavioral tests presented the same
trend for pain. A negative correlation was found between
pain behavior and the imaging data, suggesting that changes
in brain activity after CPSP are more related to changes in
thermal nociceptive sensitivity.
Pair-wise interregional correlation analysis
The ROI data of the specific brain areas that exhibited
significant differences with the SPM and ROI scores in
Table 1 Key brain regions that show significant changes in [14C] signals using two different brain imaging methods
Brain region SPM ROI
Left/Right Left/Right
Infralimbic cortex (IL) P = 1.00 P = 0.02* P = 0.00*
Prelimbic cortex (PrL) P = 1.00 P = 0.30 P = 0.00*
Cingulate cortex area 2 (Cg2) P = 0.28 P = 0.60 P = 1.00
Cingulate cortex area 1 (Cg1-1) P = 1.00 P = 0.41 P = 0.00*
Cingulate cortex area 1 (Cg1-2) P = 0.02* P = 0.04* P = 0.36
Secondary motor cortex (M2-1) P = 1.00 P = 1.00 P = 0.87
Secondary motor cortex (M2-2) P = 0.28 P = 0.04* P = 0.00*
Primary motor cortex (M1-1) P = 1.00 P = 1.00 P = 0.86
Primary motor cortex (M1-2) P = 0.58 P = 0.38 P = 0.88
Somatosensory cortex (S1-1) P = 1.00 P = 0.93 P = 0.65
Somatosensory cortex (S1-2) P = 0.53 P = 0.22 P = 0.98
Somatosensory cortex (S1-3) P = 0.00* P = 1.00 P = 1.00
Somatosensory cortex (S1-4) P = 0.00* P = 1.00 P = 1.00
Granular insular cortex (GI-1) P = 1.00 P = 0.08 P = 0.34
Granular insular cortex (GI-2) P = 0.82 P = 0.88 P = 0.85
Granular insular cortex (GI-3) P = 0.00* P = 1.00 P = 0.90
Agranular insular dorsal cortex (AID) P = 1.00 P = 0.00* P = 0.39
Agranular insular ventral cortex (AIV) P = 1.00 P = 0.03* P = 0.52
Striatum P = 0.07 P = 1.00 P = 1.00
Hippocampus (Hippo-1) P = 0.00* P = 1.00 P = 1.00
Hippocampus (Hippo-2) P = 0.00* P = 1.00 P = 1.00
Hippocampus (Hippo-3) P = 0.01* P = 0.00* P = 0.14
Mediodorsal thalamus nucleus (MD) P = 0.00* P = 0.54 P = 0.99
Ventral basal nucleus (VB) P = 0.00* P = 0.97 P = 0.00*
Ventrolateral thalamus nucleus (VL) P = 0.00* P = 1.00 P = 1.00
Ventromedial thalamus nucleus (VM) P = 0.00* P = 1.00 P = 1.00
Lateral hypothalamic area (LH) P = 0.00* P = 1.00 P = 1.00
Ventral medial hypothalamus nucleus (VMH) P = 0.00* P = 1.00 P = 1.00
Amygdala (Amygdala-1) P = 0.00* P = 1.00 P = 1.00
Amygdala (Amygdala-2) P = 0.00* P = 0.10 P = 0.01*
Periaqueductal gray (PAG) P = 0.00* P = 0.00* P = 0.50
Significant increases or decreases in [14C] uptake are noted with p values, respectively, for the SPM and ROI image signals. *p < 0.05.
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lations. The interregional correlation matrices of the
ROIs in the sham and CPSP groups are depicted in
Figures 5A and 6A, respectively. Major brain areas, such
as the cortex, hippocampus, thalamus, hypothalamus,
amygdala, and PAG, were selected for analysis. Signifi-
cant functional correlations were found between differ-
ent brain regions in the interregional correlation matrix
(p < 0.01). The diagonal line from the lower left to upper
right of the matrix is symmetrical, indicating correlations
between ROIs and themselves. The analysis identified
154 (33.3%) significant positive correlations in the sham
group (p < 0.01). The correlations between distal brainregions, such as the cortex/hippocampus, cortex/thal-
amus, cortex/hypothalamus, and cortex/amygdala, were
low. High correlations were found within different local
brain regions, such as within the cortex, thalamus, and
hypothalamus (Figure 5A). In contrast, 274 (59.3%) sig-
nificant positive correlations were found in the CPSP
group (p < 0.01). The cortex had a positive correlation
with the hippocampus, thalamus (but not VB subarea),
hypothalamus, amygdala, and PAG (Figure 6A).
The correlations in the mPFC-amygdala pathway, STT,
and MT-ACC pathway were further analyzed in the
sham (Figures 5B, C) and CPSP (Figures 6B, C) groups.
The correlations observed in the correlation matrix were
Figure 4 Region-of-interest (ROI) analysis. A. The boundaries of the ROIs were chosen based on available anatomic atlases. B. In the
comparison of the relative ratios of the left hemisphere ROIs in the different groups, the radioactivity ratios of the IL, GI-3, AID, AIV, Hippo-3, and
PAG in the CPSP group were significantly higher than in the sham group, and the Cg1-2 and M2-2 in the CPSP group were significantly lower
than in the sham group. C. In the comparison of the relative ratios of the right hemisphere ROIs in the different groups, the radioactivity ratios of
the IL, PrL, Cg1-1, and Amy-2 in the CPSP group were significantly higher than in the sham group, and the M2-2 and VB were significantly lower.
p < 0.05 (three-way ANOVA followed by post hoc test).
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the cortex (blue nodes), thalamus (red nodes), hypothal-
amus (brown nodes), amygdala (green node), and PAG
(orange node). The subregions of the mPFC (i.e., IL and
PrL) had a significant correlation with the hypothalamus
and amygdala when comparisons were made between
the sham and CPSP groups (Figure 6B). The subregions
of the ACC-thalamus pathway were positively correlatedTable 2 Pearson correlations between behavioral tests
and ROI assessment over selected brain areas
Group Correlation test Result
Sham group Plantar test vs. ROIs r = 0.01, p > 0.05
von Frey vs. ROIs r = 0.01, p > 0.05
Plantar test vs. von Frey r = 0.50, p < 0.05*
CPSP group Plantar test vs. ROIs r = −0.13, p < 0.05*
von Frey vs. ROIs r = 0.09, p > 0.05
Plantar test vs. von Frey r = −0.26, p < 0.05*
*p < 0.05, significant difference.with the PrL, Cg1, secondary motor cortex (M2), S1,
MD, VL, VMLH, and VMH (Figure 6C).
Altogether, the brain subregions in the CPSP group had
a higher percentage of correlations compared with the
same regions in the sham group, regardless of whether
they were in the STT, mPFC-amygdala pathway, or MT-
ACC pathway. These results indicate that rats with CPSP
might exhibit strong activation of the mPFC-amygdala
pathway. The high interregional correlations of subregions
of the STT and MT-ACC pathway probably reflect com-
plex connections between the thalamus and ACC.
Group differences in inter-regional correlations of
regional cerebral blood flow of neural substrates
Brain activation patterns in the left and right hemispheres
in the sham and CPSP groups are shown in Figures 7A
and B, respectively. Figure 7A shows the matrix of Fisher’s
Z-statistics, representing differences in Pearson correlation
coefficients (r) between the CPSP and sham groups in the
left hemisphere. A total of 114 significant correlations
Figure 5 Inter-regional rCBF in sham rats was analyzed by assessing correlations. Twenty-two ROIs that showed significant increases in radioactivity
counts in sham rats were included into the correlation analysis. A. Inter-regional correlation matrix for the sham group. The matrix is symmetrical across the
diagonal line from the lower left to the upper right. Notice the strong positive connections among cortical ROIs, including the cortex (IL, PrL, Cg1-1, Cg1-2,
S1-3, AID, and AIV) and thalamus (MD, VL, and VM). The connections among the VB, hypothalamus (LH and VMH), Amygdala (Amygdala-1 and Amygdala-2),
and PAG were weakly positive with this corticostriatal cluster. B. Inter-regional correlations of rCBF of the mPFC-amygdala pathway in the sham group. The
vertices (colored dots) represent ROIs of different brain areas. The connectivity map showed connections between vertices with significant correlations.
C. Graphical representation of the inter-regional correlations of rCBF of the MT-ACC pathway and STT in the sham group.
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and 30 were negative (26.3%) at the threshold of p < 0.05.
Figure 7B shows the results in the right hemisphere. A total
of 140 significant correlations were identified (30.3%), of
which 104 were positive (74.3%) and 36 were negative
(25.7%) at the threshold of p < 0.05.The pattern in the left hemisphere appeared to be simi-
lar to the right hemisphere. High correlations were found
among the cortex, hippocampus, thalamus, hypothalamus,
and amygdala. Furthermore, within the subregions of the
mPFC-amygdala pathway, the left hemisphere showed no
correlations between the mPFC (such as the IL and PRL)
Figure 6 Inter-regional rCBF in CPSP rats was analyzed by assessing correlations. Twenty-two ROIs that showed significant increases in
radioactivity counts in the CPSP group were included in the correlation analysis. A. Inter-regional correlation matrix of inter-regional rCBF
patterns in the CPSP group. Notice the augmented number of significant connections. The thalamus and hypothalamus were much more
strongly correlated with the cortex compared with the sham group (see Figure 5A). B. The inter-regional correlation of the mPFC-amygdala
pathway in the CPSP group is represented by a graph in which the connections between vertices with significant correlation are shown.
The areas of the mPFC were much more positively correlated with the MD and amygdala compared with the sham group (see Figure 5B)
C. Graphical representation of inter-regional correlations of the MT-ACC pathway and STT in the CPSP group. The cortex, thalamus, and
hypothalamus had more connections with each other.
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the mPFC were highly correlated with the amygdala in the
right hemisphere (Figure 7D).
In the left hemisphere, the ACC (such as the PrL and
Cg1) had low correlations with the VM, VL, and MD ofthe thalamus (Figure 7E). However, the right hemisphere
showed complex connections among the subregions of
the STT and MT-ACC pathway. For example, the PrL
and Cg1 had positive correlations with the MD, VM, and
VL of the thalamus (Figure 7F).
Figure 7 Differences in inter-regional correlations of rCBF of neural substrates in the CPSP and sham groups. A and B. Left and right
brain connectivity. The matrix of Fisher’s Z-statistics represents differences in Pearson correlation coefficients (r) between the CPSP and sham
groups. Positive Z values indicate a greater r in the CPSP group, and negative Z values indicate a smaller r. C-F. The inter-regional correlation of
neural substrates is represented by a graph. The ROIs are represented by nodes, and significant correlations between different ROIs are
represented by different line values. The red lines denote significant positive correlations, and blue lines denote significant negative correlations.
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The effects of lateral thalamic lesions were evaluated in the
present animal model. Lesions of the VB induced thermal
and mechanical hyperalgesia and anxiety-like responses.
The qualitative analysis revealed [14C]-IAP activation in the
mPFC, ACC, thalamus, hypothalamus, amygdala, and PAG.
The ROI analysis indicated that the IL, Cg1, M2, AID, AIV,
Hippo-3, and PAG of the left hemisphere and IL, PrL, Cg1-
1, M2, and amygdala of the right hemisphere were activated.
Activation in the lesion site (i.e., the VB) was also signifi-
cantly diminished in the right hemisphere (p < 0.05). Pain-
related behavior in the plantar test was negatively correlated
with the ROI data (p < 0.05). The CPSP group exhibited a
stronger interregional correlation of rCBF among brain net-
works compared with the sham group (p < 0.05). The CPSP
group exhibited significant correlations in the mPFC-
amygdala pathway, STT, and MT-ACC pathway (p < 0.05).
The comparison of the left and right hemispheres in the
CPSP and sham groups showed that the neural subregions
of the mPFC-amygdala pathway, STT, and MT-ACC path-
way were significantly correlated in the right hemisphere
compared with the left hemisphere in the CPSP group (p <
0.05). The present results indicate that rats with VB lesions
exhibit symptoms of CPSP following hemorrhagic stroke.
The behavioral tests revealed a lower nociceptive threshold
in response to thermal and mechanical stimulation in the
VB lesion group (p < 0.05). The present [14C]IAP analysis in-
dicated that the mPFC, ACC, thalamus, hypothalamus,
amygdala, and PAG were more activated than other brain
structures in CPSP. The inter-regional analysis of correla-
tions of rCBF showed that the STT, MT-ACC pathway, and
amygdala-mPFC pathway were significantly activated. To
our knowledge, no previous study has investigated brain ac-
tivation and CPSP using the [14C]IAP approach. Our [14C]
IAP uptake findings in CPSP, however, are not entirely con-
sistent with previous [14C]IAP studies that used an animal
model of acute pain. For example, colorectal distension elic-
ited significant enhancements in rCBF in the insula cortex,
somatosensory cortex, ACC, and amygdala, but the thal-
amus, parabrachial nucleus, PAG, hypothalamus, and pons
showed decreases in rCBF [27]. Furthermore, a study that
used a passive avoidance conditioned learning paradigm
with noxious colorectal distension to induce visceral pain
demonstrated that rats with acute pain conditioning exhib-
ited brain activation in the anterior insula, somatosensory
cortex, ACC, PrL, and amygdala [28]. Although the experi-
mental paradigms used different animal models of pain, the
ACC and amygdala were both shown to be common brain
areas involved in acute and chronic pain.
The ACC is an important part of the medial pain path-
way. Previous studies showed that brain areas in the STT
and MT-ACC pathway, including the ACC, are implicated
in CPSP [7,11,12]. With regard to the involvement of the
STT and MT-ACC pathway in CPSP, the lateral thalamuswas thought to disrupt the inhibition of signaling to the
MT, resulting in mechanical allodynia and thermal hyper-
algesia [6,7]. This impairment of inhibition has been
shown to result from lesions of the STT, producing thal-
amic hyperexcitability at the neural level, thermal hyper-
algesia, and mechanical allodynia [27]. Clinical studies
have also shown that the STT and MT-ACC pathway, par-
ticularly the ACC, mediate pain responses in CPSP pa-
tients. For example, CPSP patients who were subjected to
different thermonociceptive stimuli and underwent fMRI
showed pain-specific signal changes in the anterior cingu-
late gyrus and associative parietal regions [24]. A recent
clinical brain mapping study suggested that the ventral
posterior nucleus and pulvinar border zone were involved
in CPSP, but the VPL was not [15,17]. Therefore, basic
and clinical studies of CPSP suggest that the MT-ACC
pathway and STT play crucial roles in CPSP.
Our inter-regional correlation of rCBF analysis showed
that subregions of the mPFC (e.g., IL, Cg1, Cg2, and PrL)
were more connected to the amygdala in the CPSP group.
The qualitative [14C] analysis and quantitative ROI ana-
lysis also indicated that mPFC nuclei, such as the IL and
PrL, were also involved in CPSP. Therefore, the amygdala
and mPFC may both mediate part of the symptoms of
CPSP. According to previous data [19-23], the mPFC
might be a high-level controller of cognition that elabo-
rates or regulates emotional content from the amygdala,
whereas the amygdala governs the emotional response to
pain [29-31]. Additionally, the mPFC and amygdala might
play different functional roles. For example, the adminis-
tration of D-cycloserine, an N-methyl-D-aspartate recep-
tor partial agonist, into the mPFC or amygdala reduced
neuropathic pain in a spared nerve injury model [32]. The
glutamatergic system may be involved in antinociception
in the mPFC-amygdala pathway, and other neurotransmit-
ters may mediate the nociceptive effect in the mPFC-
amygdala pathway [33].
The present findings of the involvement of the PAG in
CPSP appear to be consistent with previous studies with re-
gard to the crucial role of the PAG in descending control
[34-36]. For example, a recent study that used electrophysio-
logical recordings suggested that noxious and innocuous
cold information was transmitted through descending sys-
tems via the PAG to process acute or chronic pain [34]. A
behavioral pharmacology study showed that microinjection
of lidocaine, a sodium ion channel inhibitor, into the PAG
impaired noxious information transfer from the medial or
central amygdala, and reflected by decreases in the latency
of the tail flick reflex [35]. Furthermore, a recent study dem-
onstrated that oxytocin perfusion into the PAG decreased
pain thresholds, indicating that the PAG may be involved in
antinociceptive processing through oxytocin systems [36].
Therefore, the PAG might also play an important role in de-
scending modulatory control in CPSP.
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model of CPSP may be proposed that involves changes in
various structures, pathways, and circuits (Figure 8). The
neural correlation hypothesis of CPSP-induced posits that
pain symptoms are associated with spontaneous pain rather
an acute pain, which would be different from conventional
pain theories. CPSP is likely mediated by multiple patho-
physiological mechanisms that involve alterations in various
neural substrates. When the VB is damaged in hemorrhagic
stroke, pathophysiological mechanisms are triggered in the
STT and MT-ACC pathway, in which projections from theFigure 8 Neural network hypothesis related to the present animal mo
pathway and STT are triggered to disinhibit the projection from the lateral
and thermal hyperalgesia. B. The mPFC plays an executive function role to
information. The mPFC inhibits activation of the amygdala, whereas negati
then interprets the emotional information properly. Nociceptive informatio
chronic pain to induce antinociception.lateral thalamus (including the VPM) and insula to the med-
ial thalamus (e.g., the MD) are disinhibited, thus resulting in
mechanical and thermal hyperalgesia (Figure 8A) [6-8]. Al-
ternative neural pathways, including the mPFC, amygdala,
and PAG, were activated during the pathophysiological
changes (Figure 8B). The mPFC, including the PrL and IL,
plays a role in executive function and interacts with central
or medial nuclei of the amygdala that respond to negative
emotion. The mPFC might inhibit activation of the amyg-
dala, whereas negative information from the amygdala is
conveyed to the mPFC and mPFC to interpret thedel of CPSP. A. Pathophysiological mechanisms in the MT-ACC
thalamus and insula to the medial thalamus, resulting in mechanical
interact with the amygdala, which responds to negative emotional
ve information in the amygdala is conveyed to the mPFC. The mPFC
n from the amygdala is transmitted to the PAG to process acute and
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information from the amygdala is transmitted to the PAG to
process acute and chronic pain and induce antinociception.
The neural correlation hypothesis of CPSP may have im-
plications for clinical interventions. For example, pharmaco-
logical and nonpharmacological approaches can be applied
to activate the neural circuits of the mPFC and PAG and in-
hibit amygdala activity. Hemorrhagic insult triggers a series
of pathophysiological changes in pain-related brain areas, in-
cluding cortical and subcortical structures. Such CPSP-
associated changes also trigger a series of brain disorders,
such as emotional fear, anxiety, depression, and impairment
of cognitive function. Elucidation of the alterations in brain
activation patterns and circuit connectivity in CPSP could
provide insights into the extensive pathophysiological mech-
anisms that underlie the multi-faceted manifestations of
CPSP. Effective therapeutic interventions would rely on a
better understanding of the complex relationship between
pain and emotional disorders and identify the cellular and
molecular targets that contribute to these processes.
An interesting issue is why the occurrence of CPSP al-
ters the relationship between the plantar test and von
Frey test results and functional brain imaging. According
to the data presented in Table 2, the von Frey and plan-
tar test results were in the same direction in the sham
group. In the CPSP group, in contrast, the von Frey and
plantar test results presented a significant negative cor-
relation. The correlation data also showed that the von
Frey test result showed a nonsignificant correlation with
the ROI brain imaging data. Different sensitivity of noci-
ceptive responses has been reported in CPSP patients
[7]. In the present study, behavioral responses in the von
Frey test after CPSP did not show a negative correlation.
This issue of differential nociceptive sensitivity in CPSP
should be investigated in further studies.Conclusions
The present data were consistent with the previous findings
that the STT and thalamocingulate pathway play a crucial
role in the pathophysiology of CPSP symptoms. The mPFC,
amygdala, and PAG were involved in important connectivity
related to pain processing in CPSP. The present data may
have implications for novel CPSP treatments.Methods
Experimental animals
Fourteen male Sprague–Dawley rats (300–400 g) were
housed in an air-conditioned room (21-23°C; 50% humid-
ity; 12 h/12 h light /dark cycle, lights on at 8:00 AM) with
free access to food and water. All of the experiments were
performed in accordance with the guidelines of the Aca-
demia Sinica Institutional Animal Care and Utilization
Committee.Surgical procedures
The rats were initially anesthetized with 4% isoflurane (in
100% O2), and body temperature were maintained at 36.5-
37.5°C with a homeothermic blanket system (Model 50–
7079, Harvard Apparatus, Holliston, MA, USA). The rats
were randomly and equally assigned to the CPSP (n = 7)
and sham (n= 7) groups. The CPSP rats were injected with
0.125 U of type 4 collagenase in 0.5 μl saline in the VPM
and VPL (coordinates: 3.0-3.5 mm posterior and 3.0-
3.5 mm lateral to bregma, 5.5-5.8 mm depth) [26]. The
sham animals were injected with 0.5 μl sterile saline in the
same region. The animals were injected with antibiotic
(6 mg/kg gentamycin, i.p.) to prevent infection, and they
were weighed before and after the lesion procedure. Only
animals whose body weights recovered after surgery were
included in the experiment. At week 4, the rats were sub-
jected to the same anesthesia procedure. To prepare for ra-
diotracer infusion in awake, freely moving rats, the right
external jugular vein was isolated and catheterized with
polyethylene-50 tubing. A port at the terminal end of the
tube was subcutaneously tunneled and fixed to the back
skin. The animals were allowed to recover for 7 days before
the last behavioral test at week 5 and radiotracer infusion.
To prevent blockage of the tube, it was flushed every other
day after surgery with 0.3 ml of 0.9% saline, followed by
0.1 ml of saline with 20 U/ml heparin.
Behavioral testing
To measure mechanical and thermal nociceptive re-
sponses, von Frey and plantar tests were applied on the bi-
lateral hind paws before the lesion procedure and 7, 14,
21, 28, and 35 days after the collagenase injection. Persist-
ent pain behavior was evaluated in the open field test.
von Frey test
In this study, mechanical hyperalgesia was assessed by meas-
uring the withdrawal response to a mechanical stimulus
using a von Frey esthesiometer. The animals were placed on
an elevated mesh platform for 30 min before testing, which
provided access to the plantar surface of the hind paw. A
rigid tip attached to the meter was applied to the plantar
surface from under the floor, and filaments were gradually
applied with ascending, graded force to determine the min-
imal force that would elicit a withdrawal response. The
threshold was defined as the average of three minimal forces
measured in consecutive trials, each separated by 5 min.
Plantar test
Thermal hyperalgesia was assessed by measuring the hind
paw withdrawal latency in response to radiant heat using a
plantar test apparatus (IITC 390G Plantar Test, IITC Life
Science, Woodland Hills, CA, USA). Each rat was placed
in a transparent Plexiglas box for 30 min before testing,
and the mobile infrared source was delivered through the
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infrared light source to assess withdrawal responses, giving
withdrawal latencies of 0–20 s. The latency of the with-
drawal response was the time that elapsed between press-
ing and releasing the button for infrared stimulation. Each
rat was tested in three trials with the right and left hind
paws, respectively. The intertrial interval was 5 min.
Radiotracer injection and brain perfusion
On day 35 after the behavioral test, a syringe was filled
with the radiotracer [14C]IAP (125 μCi/kg in 0.3-0.5 ml;
American Radiolabelled Chemicals, St. Louis, MO, USA).
The radiotracer-filled tubing was then connected to the
animal’s cannula. The other end of the cannula was con-
nected to a syringe filled with euthanasia agent (3 M po-
tassium chloride). After resting for 5 min, anesthesia-free
rats were infused with the radiotracer at a rate of 2.25 ml/
min through the external jugular vein. The animals were
euthanized with 4% isoflurane for gas anesthesia and
0.5 ml of 3 M potassium chloride (i.v.) approximately 10 s
after the cessation of radiotracer infusion. The brains were
rapidly removed 1 min after euthanasia, quickly frozen in
dry ice/methylbutane (approximately −55°C), and embed-
ded in Optimal Cutting Temperature compound (Sakura
Fintek, Torrance, CA, USA).
Autoradiography
Brain mapping was performed using an autoradiographic
method [37,38]. Perfusion autoradiography was conducted
for the whole-brain assessment of brain activation in
awake, unrestrained animals. A 10-s time window for the
radiotracer injection provided the specific timing for [14C]
uptake in brain tissue. This time condition of the radio-
tracer injection is appropriate for evoked pain [39]. How-
ever, the spontaneous pain associated with CPSP is
assumed to be constant and persistent pain. The 10-s time
window for the radiotracer injection is also suitable for
measuring spontaneous pain associated with CPSP. There-
fore, the brain images showed the signal strength of [14C]
radioactivity. The uptake of the [14C] radiotracer was de-
termined by measuring the pixel intensity in selected
ROIs. The signal of the pixel intensity is expressed as
pixels per square millimeter. To normalize the images ob-
tained from brain slices from different rats, the ROI pixel
intensity was transformed to radioactivity count based on
the method of Brandt et al. [40]. The signal of the radio-
activity count is expressed as the beta count per square
millimeter.
The amount of [14C] in brain tissue was calibrated using
densitometric measurements. The first step was to estab-
lish the relationship between the pixel intensity and radio-
activity count. Five different doses of [14C] (0.001, 0.01,
0.1, 1, and 10 μCi) were dropped onto 25 mm2 filter paper.
The pixel intensities of each image of the filter paperswere measured and correlated with the radioisotope count
of each filter paper. Images were obtained by exposure to
exposure cassettes with a phosphor screen (Amersham
Biosciences, Piscataway, NJ, USA) at −20°C and digitized
using 8-bit gray scale in Typhoon 9410 Variable Mode
Imager (WS-S9410, GMI, Ramsey, MN, USA). The radio-
activity count was obtained using a γ-counter (Beckman
LS 6500 Liquid Scintillation Counter, Beckman Coulter,
Brea, CA, USA) to evaluate the radioactivity count of the
filter papers. Furthermore, the data were conducted a liner
regression analysis for the pixel intensity and radioactivity
count, and then Equation 1 (Y = 824.48 X −23020; see
Figure 1) was obtained.
In the second step, brain slices were prepared, and the
radioisotope counts of the brain tissues were estimated
from Equation 1 by calculating the pixel intensity of the
ROI image. Coronal slices (20 μm thick) were sectioned
on a cryostat (Leica CM1850, Leica Biosystems Nussloch
GmbH, Nussloch, BW, Germany) at −20°C, and the
interval between each slice was 240 μm. The slices were
dried on glass slides and placed alongside five standard
filter papers with graded radioactivity. All of the slides
were exposed to Amersham Biosciences exposure cas-
settes at −20°C. The images of the brain sections were
then digitized. To quantify the [14C] signal from the
ROIs of the different rat brain slices, the pixel intensity
obtained from each brain slice was normalized based on
the value of the five standard filter papers, and the radio-
activity count was calculated according to Equation 1 to
transform the pixel intensity. The ROI signals were
transformed into an X value using this equation, and
these X values indicated the quantitative radioactivity
counts. To determine the best exposure time, the brain
slices were measured from 1 to 5 days.
Data analysis
Statistical parametric mapping
Statistical Parametric Mapping (SPM, version 8, Wellcome
Centre for Neuroimaging, University College London,
London, UK), a software package developed for the analysis
of functional brain imaging data, was adapted for the ana-
lysis of rat brain autoradiography. The pixel count was re-
placed by the pixel intensity, quantified autoradiographically,
and analyzed using SPM and the ROIs, respectively. A
three-dimensional brain image was reconstructed using 62
serial coronal sections (starting at bregma +4.8 mm). Adja-
cent sections were aligned both manually and using Stack-
Reg, an automated pixel-based registration algorithm in
ImageJ software (version 1.46; http://imagej.nih.gov/ij). All
of the original three-dimensionally reconstructed brains
were smoothed and normalized to the reference rat brain
model and divided into sham and CPSP groups. Following
the formation of these two groups, all of the brains were av-
eraged to create the final brain template. To determine
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groups, the images were derived by subtracting the sham
group from the CPSP group. Finally, we chose key brain
slice images to show significant differences in pixel counts
between the CPSP and sham groups.Region of interest analysis
The ROI was functionally defined as a set of pixel inten-
sities of a brain area that showed [14C] uptake in brain
tissue. A total of 63 anatomical ROIs (31 on each side of
the brain plus the cerebellum as a reference ROI) were
first depicted in ImageJ over the template brain accord-
ing to the rat brain atlas [41], and the following brain re-
gions were measured: cortex (IL, PrL, Cg2, Cg1, M2,
M1, S1, GI, AID, AIV), striatum, Hippo, thalamus (MD,
VB, VL, and VM), hypothalamus (LH and VMH), amyg-
dala, and PAG. To quantify and make comparisons be-
tween the ROIs from the different groups, ROI signals
were normalized to obtain the ratio of radioactivity in
each ROI. The ratio was obtained by the following
Equation 2:




In Equation 1, the mean radioactivity value X was trans-
formed from Equation 2 from the ROI of the different
rat brain slices. X equals the mean radioactivity signal of
the ROI. Xb equals the mean signal of radioactivity of
the selected background region. Xref is the mean signal
of radioactivity of a reference ROI (i.e., the cerebellum).
Pearson correlations were performed for pain-related be-
havior (including the plantar test and von Frey test) and
ROIs of selected brain areas, respectively.Inter-regional correlation of regional cerebral blood
flow analysis
Two different statistical analyses were performed to de-
termine the inter-regional correlations of rCBF. To clar-
ify the relative contribution of the ratio of the ROIs in
each group, a correlation coefficient analysis was first
performed, and the data were displayed in an inter-
regional correlation matrix. The next part of the analysis
used Pearson correlation coefficients to examine the re-
lationships between the CPSP and sham groups. An
inter-regional correlation matrix was calculated across
animals from each group using MatLab (version 2009b,
MathWorks, Natick, MA, USA) and visualized as color
maps. The correlation coefficients were transformed
into Z scores using equation of Fisher transformation,












r1 and r2 are the Pearson coefficients in the CPSP group
and sham group, and r1 is greater than r2.
Graphical theoretical analysis was performed on net-
works defined by the above correlation matrices using
Pajek software (version 3.06; http://Pajek.imfm.si/). In
the graph, a brain area is represented by a node, and a
significant correlation between the two nodes is linked
by edges. The nodes were arranged so that neighboring
nuclei were placed closer to each other, and more distal
nuclei were placed further apart. The Z scores of the
correlation coefficients were used to define the strength
of the edges, and edges that were thicker indicated that
the Z scores had major significant differences.
Statistical significance inferences
A 2 × 5 two-way mixed ANOVA, with group and weeks
as factors, was conducted to assess the duration of heat
tolerance in the plantar test and mechanical force in the
von Frey test in the sham and CPSP groups in the pre-
test and at weeks 1–5. When appropriate, Tukey’s HSD
post hoc test was conducted. For the quantitative SPM
and radioactivity ratio analysis, a 2 × 31 × 2 (group vs.
brain area vs. hemisphere) three-way ANOVA was con-
ducted. A 2 × 31 two-way ANOVA was also conducted,
with group and brain area as factors. When appropriate,
Tukey’s HSD post hoc test was conducted. Pearson cor-
relation coefficients were calculated to assess the corre-
lations among all of the selected brain areas in the sham
and CPSP groups across the whole subject pool. How-
ever, the ROI data of selected brain areas were further
analyzed using the Pearson correlation test after deter-
mining significant brain areas in the ANOVA (i.e., a cor-
rection method to replace the whole brain areas).
Moreover, the matrix of Fisher’s Z-statistics was ana-
lyzed using Pearson correlation coefficients between the
sham and CPSP groups in the left and right hemi-
spheres. Values of p < 0.05 and 0.01 were considered sta-
tistically significant in the ANOVA and Pearson
correlation tests, respectively.
Abbreviations
ACC: Anterior cingulate cortex; AID: Dorsal agranular insular cortex;
AIV: Ventral agranular insular cortex; ANOVA: Analysis of variance;
Cg1: Cingulate cortex area 1; Cg2: Cingulate cortex area 2; CPSP: Central
post-stroke pain; fMRI: Functional magnetic resonance imaging; GI: Granular
insular cortex; Hippo: Hippocampus; HSD: Honestly significant difference;
IAP: Iodoantipyrine; IL: Infralimbic cortex; LH: Lateral hypothalamic area;
M1: Primary motor cortex; M2: Secondary motor cortex; MD: Mediodorsal
thalamic nucleus; MT: Medial thalamus; mPFC: Medial prefrontal cortex;
PAG: Periaqueductal gray; PET: Positron emission tomography; PrL: Prelimbic
cortex; QST: Quantitative sensory testing; rCBF: Regional cerebral blood flow;
ROI: Region of interest; SPECT: Single-photon emission computed
tomography; SPM: Statistical parametric mapping; S1: Somatosensory cortex;
STT: Spinothalamic tract; VB: Ventral basal nucleus; VL: Ventrolateral thalamic
Lu et al. Molecular Pain  (2015) 11:9 Page 16 of 17nucleus; VM: Ventromedial thalamic nucleus; VMH: Ventromedial
hypothalamic nucleus; VMpo: Posterior portion of the ventral medial nucleus;
VPL: Ventral posterolateral thalamic nucleus; VPM: Ventral posteromedial
thalamic nucleus.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HCL participated in the design of the study, conducted the experiments,
analyzed the data, and drafted the manuscript. WJC participated in the
design of the surgical procedures. YHK participated in the open field test.
ACWH coordinated and helped draft the manuscript and performed the
statistical analysis. BCS conceived of the study, participated in its design and
coordination, and participated in writing the manuscript. All of the authors
read and approved the final manuscript.
Acknowledgements
The authors thank Ms. Ting Ting Lee from the Security Division of the
Institute of Biomedical Sciences for technical advice. The present study was
supported by National Science Council grants to Dr. Bai-Chuang Shyu
(NSC 99-2320-B-001-016-MY3, NSC 100-2311-B-001-003-MY3, and NSC
102-2320-B-001-026-MY3). This work was undertaken at the Institute of
Biomedical Sciences, which received funding from Academia Sinica.
Author details
1Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.
2Department of Psychology, Fo Guang University, Yilan 26247, Taiwan.
Received: 21 February 2014 Accepted: 17 February 2015
References
1. Jensen TS, Lenz FA. Central post-stroke pain: a challenge for the scientist
and the clinician. Pain. 1995;61:161–4.
2. Lee MC, Zambreanu L, Menon DK, Tracey I. Identifying brain activity
specifically related to the maintenance and perceptual consequence of
central sensitization in humans. J Neurosci. 2008;28:11642–9.
3. Finnerup NB. A review of central neuropathic pain states. Curr Opin
Anaesthesiol. 2008;21:586–9.
4. Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: clinical characteristics,
pathophysiology, and management. Lancet Neurol. 2009;8:857–68.
5. Kumar G, Soni CR. Central post-stroke pain: current evidence. J Neurol Sci.
2009;284:10–7.
6. Craig AD, Bushnell MC, Zhang ET, Blomqvist A. A thalamic nucleus specific
for pain and temperature sensation. Nature. 1994;372:770–3.
7. Greenspan JD, Ohara S, Sarlani E, Lenz FA. Allodynia in patients with post-
stroke central pain (CPSP) studied by statistical quantitative sensory testing
within individuals. Pain. 2004;109:357–66.
8. Wang G, Thompson SM. Maladaptive homeostatic plasticity in a rodent
model of central pain syndrome: thalamic hyperexcitability after
spinothalamic tract lesions. J Neurosci. 2008;28:11959–69.
9. del Rey A, Apkarian AV, Martina M, Besedovsky HO. Chronic neuropathic
pain-like behavior and brain-borne IL-1β. Ann N Y Acad Sci. 2012;1262:101–7.
10. Denk F, McMahon SB, Tracey I. Pain vulnerability: a neurobiological
perspective. Nat Neurosci. 2014;17:192–200.
11. Su YL, Huang J, Wang N, Wang JY, Luo F. The effects of morphine on basal
neuronal activities in the lateral and medial pain pathways. Neurosci Lett.
2012;525:173–8.
12. Zhang Y, Wang N, Wang JY, Chang JY, Woodward DJ, Luo F. Ensemble
encoding of nociceptive stimulus intensity in the rat medial and lateral pain
systems. Mol Pain. 2011;7:64.
13. Martin RJ, Apkarian AV, Hodge Jr CJ. Ventrolateral and dorsolateral
ascending spinal cord pathway influence on thalamic nociception in cat.
J Neurophysiol. 1990;64:1400–12.
14. Craig (Bud) AD. Mechanisms of thalamic pain. In: Henry JL, Panju A, Yashpal K,
editors. Central neuropathic pain: focus on poststroke pain. Seattle: IASP Press;
2007. p. 81.
15. Sprenger T, Seifert CL, Valet M, Andreou AP, Foerschler A, Zimmer C, et al.
Assessing the risk of central post-stroke pain of thalamic origin by lesion
mapping. Brain. 2012;135:2536–45.16. Kalita J, Kumar B, Misra UK, Pradhan PK. Central post stroke pain: clinical,
MRI, and SPECT correlation. Pain Med. 2011;12:282–8.
17. Krause T, Brunecker P, Pittl S, Taskin B, Laubisch D, Winter B, et al.
Thalamic sensory strokes with and without pain: differences in lesion
patterns in the ventral posterior thalamus. J Neurol Neurosurg
Psychiatry. 2012;83:776–84.
18. Symonds LL, Gordon NS, Bixby JC, Mande MM. Right-lateralized pain
processing in the human cortex: an fMRI study. J Neurophysiol.
2006;95:3823–30.
19. Ji G, Neugebauer V. Modulation of medial prefrontal cortical activity using
in vivo recordings and optogenetics. Mol Brain. 2012;5:36.
20. Ji G, Neugebauer V. CB1 augments mGluR5 function in medial prefrontal
cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model.
Eur J Neurosci. 2014;39:455–66.
21. Ji G, Sun H, Fu Y, Li Z, Pais-Vieira M, Galhardo V, et al. Cognitive impairment in
pain through amygdala-driven prefrontal cortical deactivation. J Neurosci.
2010;30:5451–64.
22. Crock LW, Kolber BJ, Morgan CD, Sadler KE, Vogt SK, Bruchas MR, et al.
Central amygdala metabotropic glutamate receptor 5 in the modulation of
visceral pain. J Neurosci. 2012;32:14217–26.
23. Neugebauer V, Li W, Bird GC, Bhave G, Gereau 4th RW. Synaptic
plasticity in the amygdala in a model of arthritic pain: differential roles
of metabotropic glutamate receptors 1 and 5. J Neurosci.
2003;23:52–63.
24. Seghier ML, Lazeyras F, Vuilleumier P, Schnider A, Carota A. Functional
magnetic resonance imaging and diffusion tensor imaging in a case of
central poststroke pain. J Pain. 2005;6:208–12.
25. Jungehulsing GJ, Israel H, Safar N, Taskin B, Nolte CH, Brunecker P, et al.
Levetiracetam in patients with central neuropathic post-stroke pain: a randomized,
double-blind, placebo-controlled trial. Eur J Neurol. 2013;20:331–7.
26. Wasserman JK, Koeberle PD. Development and characterization of a
hemorrhagic rat model of central post-stroke pain. Neuroscience.
2009;161:173–83.
27. Wang Z, Bradesi S, Maarek JM, Lee K, Winchester WJ, Mayer EA, et al.
Regional brain activation in conscious, nonrestrained rats in response to
noxious visceral stimulation. Pain. 2008;138:233–43.
28. Wang Z, Bradesi S, Charles JR, Pang RD, Maarek JM, Mayer EA, et al.
Functional brain activation during retrieval of visceral pain-conditioned
passive avoidance in the rat. Pain. 2011;152:2746–56.
29. Kim MJ, Loucks RA, Palmer AL, Brown AC, Solomon KM, Marchante AN,
et al. The structural and functional connectivity of the amygdala: from
normal emotion to pathological anxiety. Behav Brain Res.
2011;223:403–10.
30. Koenigs M, Grafman J. Posttraumatic stress disorder: the role of medial
prefrontal cortex and amygdala. Neuroscientist. 2009;15:540–8.
31. Townsend JD, Torrisi SJ, Lieberman MD, Sugar CA, Bookheimer SY, Altshuler
LL. Frontal-amygdala connectivity alterations during emotion downregulation
in bipolar I disorder. Biol Psychiatry. 2013;73:127–35.
32. Millecamps M, Centeno MV, Berra HH, Rudick CN, Lavarello S, Tkatch T, et al.
D-cycloloserine reduces neuropathic pain behavior through limbic NMDA-
mediated circuitry. Pain. 2007;132:108–23.
33. de Novellis V, Vita D, Gatta L, Luongo L, Bellini G, De Chiaro M, et al.
The blockade of the transient receptor potential vanilloid type 1 and
fatty acid amide hydrolase decreases symptoms and central sequelae in
the medial prefrontal cortex of neuropathic rats. Mol Pain. 2011;7:7.
34. Leith JL, Koutsikou S, Lumb BM, Apps R. Spinal processing of noxious and
innocuous cold information: differential modulation by the periaqueductal gray.
J Neurosci. 2010;30:4933–42.
35. Oliveira MA, Prado WA. Role of PAG in the antinociception evoked
from the medial or central amygdala in rats. Brain Res Bull.
2001;54:55–63.
36. Yang J, Liang JY, Li P, Pan YJ, Qiu PY, Zhang J, et al. Oxytocin in the
periaqueductal gray participates in pain modulation in the rat by
influencing endogenous opiate peptides. Peptides. 2011;32:1255–61.
37. Sakurada O, Kennedy C, Jehle J, Brown JD, Carbin GL, Sokoloff L.
Measurement of local cerebral blood flow with iodo [14C] antipyrine. Am J
Physiol. 1978;234:H59–66.
38. Ginsberg MD, Busto R, Boothe TE, Campbell JA. A radioisotopic method for
the simultaneous quantitation of regional cerebral blood flow and glucose
utilization in small dissected samples: validation studies and values in the
nitrous oxide-anesthetized rat. Brain Res. 1981;230:165–79.
Lu et al. Molecular Pain  (2015) 11:9 Page 17 of 1739. Holschneider DP, Maarek JM, Harimoto J, Yang J, Scremin OU. An
implantable bolus infusion pump for use in freely moving, nontethered rats.
Am J Physiol Heart Circ Physiol. 2002;283:H1713–9.
40. Brandt MP, Kloos RT, Shen DH, Zhang X, Liu YY, Jhiang SM. Micro-single-
photon emission computed tomography image acquisition and quantification
of sodium-iodide symporter-mediated radionuclide accumulation in mouse
thyroid and salivary glands. Thyroid. 2012;22:617–24.
41. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. San
Diego: Academic Press; 2007.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
